3 sources verified·1 min read
By Lyrie Threat Intelligence·4/23/2026
Healthcare AI Firm Sued Over Alleged Unlawful Disclosures of Genetic Data
Source: DataBreaches.net
Published: Thu, 23 Apr 2026 16:59:40 +0000
Summary
Steve Alder reports: Tempus AI, a publicly traded healthcare artificial intelligence company, is facing multiple class action lawsuits over the alleged unauthorized collection and disclosure of genetic testing results, which were derived from genetic testing by Ambry Genetics Corporation (Ambry Genetics). Tempus AI used Ambry Genetics’ genetic database to train its AI models. Tempus AI...
Source
Sources
Lyrie Verdict
Lyrie's autonomous defense layer flags this class of exposure the moment it surfaces — no signature update required.